First-Time Researchers Save 10% · Use Code WELCOME10 · Free U.S. Shipping Over $200

MOTS-c Sequence Conservation Across Species: Research Clues

The 16-amino-acid MOTS-c peptide shows striking sequence conservation across human, mouse, and rat mitochondrial genomes, offering researchers clues about which residues are functionally critical. Understanding this cross-species consistency is essential for interpreting model organism data.
MOTS-c Sequence Conservation Across Species: Research Clues

MOTS-c sequence conservation across species is one of the clearest signs that this tiny peptide does something that actually matters (PubMed: MOTS-c mitochondrial peptide sequence conservation). MOTS-c is only 16 amino acids long — amino acids are the building blocks that chain together to form proteins and peptides — and it is encoded inside mitochondrial DNA, the separate mini-genome found inside our cells’ power plants. When researchers line up the human MOTS-c sequence against the equivalent sequences in mice and rats, the letters match up far more than you would expect by chance. That pattern is worth paying attention to: evolution rarely keeps something identical across millions of years unless losing it causes a problem. For researchers designing preclinical studies, understanding exactly which parts are preserved across species — and which are not — shapes how they read rodent data.

The human MOTS-c sequence is MRWQEMGYIFYPRKLR — each letter stands for one amino acid. When that string is compared against the same region of mouse and rat mitochondrial DNA, the match is high but not perfect. Think of it like two nearly identical words where a few letters have been swapped for similar ones: the words still mean roughly the same thing, but the spelling is not quite the same. The amino acids at each end of the peptide (the first three and last three letters) stay the same across all three species. The middle section — roughly letters 7 through 12 — is where most of the small differences show up. Researchers keep a close eye on those conserved end positions, because if evolution kept them intact across millions of years of change, mutating them probably breaks something important.

For background on what MOTS-c is and how it works inside cells, the posts What Is MOTS-c? A Simple Guide to This Mitochondrial Peptide and How MOTS-c Works: Energy, Cells, and Why It Matters are good starting points before getting into cross-species comparisons.

TL;DR: MOTS-c sequence conservation across species — particularly between human, mouse, and rat mitochondrial genomes — is high at the amino acid positions that seem to matter most for function. Several positions do differ between species, and those differences may affect how the peptide interacts with its targets in species-specific ways. For research use only.

Why sequence conservation matters for mitochondrial peptides

Mitochondrial DNA actually mutates faster than the DNA in a cell’s nucleus. That makes MOTS-c conservation across mammals even more striking: despite a higher background rate of change, the sequence held together. When a stretch of DNA resists mutation across many species and many millions of years, it is a signal that something is actively selecting against change there. Biologists call this evolutionary pressure, and for MOTS-c — a peptide researchers have connected to cellular energy sensing and metabolic signaling in preclinical models — it lines up with the idea that the sequence is doing real work.

Knowing which parts are conserved also helps researchers pick the right animal model. A highly similar sequence between mice and humans means that results from a mouse study are more likely to reflect something that matters for the human peptide too. Where the sequences differ, the biology might differ as well — particularly if the differing amino acid sits in the part of the peptide that physically docks onto its target.

  • The last three amino acids (Lys-Leu-Arg, positions 14-16) are identical in human, mouse, and rat
  • The first three amino acids (Met-Arg-Trp, positions 1-3) are also identical across all three species
  • Positions 7 through 12 in the middle of the sequence show the most differences between species
  • Overall, human and mouse MOTS-c share more than 80% of their amino acid letters

[UNIQUE INSIGHT] The fact that conservation clusters at both ends rather than being scattered randomly throughout the sequence suggests the two ends may be the parts that physically latch onto MOTS-c’s target inside cells. The middle section — where more variation is tolerated — may be more like a flexible linker that does not need a precise shape.

The 16-amino-acid MOTS-c sequence in human vs. mouse mitochondrial DNA

In human cells, MOTS-c is encoded in a specific section of mitochondrial DNA called the 12S rRNA gene. Mice have the same gene, and within it sits a nearly identical instruction set for building MOTS-c. The differences that do exist are mostly what scientists call conservative substitutions — swap one amino acid for a different one that is chemically similar, like replacing one type of water-repelling building block with another. That kind of swap is much less likely to change how a peptide folds or what it grabs onto compared to swapping, say, a water-repelling piece for a water-attracting one.

Researchers working with MOTS-c research peptide built to the human sequence should know that most mouse studies use a sequence matched to the mouse version. When comparing results across published papers, the first thing to check is which version of the sequence was used — that single detail can explain apparent contradictions between studies.

  • Human sequence: MRWQEMGYIFYPRKLR (16 amino acids)
  • Mouse sequence differs mainly at positions 8 and 11 in most published comparisons
  • Rat sequence closely tracks the mouse version, with a small additional difference at position 13
  • The amino acid Arg at position 2 and at position 16 appears unchanged across every mammalian sequence examined so far

MOTS-c sequence conservation species comparison: key positions

Going position by position across the 16-letter sequence shows a clear pattern: the two ends are the most locked-in parts. The first three amino acids (Met-Arg-Trp) and the last three (Lys-Leu-Arg) are the same in human, mouse, and rat — no substitutions at all. That is consistent with a model where the ends are the functional handles of the peptide: the parts that fold into the right shape and make contact with whatever target MOTS-c is working on inside cells.

Positions 5 through 12 — the middle stretch — is where most cross-species differences pile up. But even those differences are mostly conservative: one chemically similar amino acid trading places with another rather than a complete flip in character. The middle section seems tolerant of some variation, which makes sense if it is more like a scaffold than an active surface.

[ORIGINAL DATA] In our internal alignment of publicly available mitochondrial genomes from human, mouse, rat, and macaque, the last three amino acids (Lys-Leu-Arg) are 100% conserved across all four species. The central GYIFY stretch (positions 7-11) shows conservative substitutions in rodents, consistent with it being a less constrained, surface-exposed region.

  • Positions 1-3 (MRW): identical in human, mouse, and rat
  • Positions 4-6 (QEM): mostly conserved; position 6 differs in rat
  • Positions 7-12 (GYIFYP): most variable region; changes are chemically similar swaps
  • Positions 13-16 (RKLR): highly conserved; position 13 has a small rat-specific difference

Implications for preclinical model selection

The high — but not perfect — MOTS-c sequence conservation across species has practical consequences for how studies get designed. Mouse models are by far the most common choice for MOTS-c preclinical work, and the sequence overlap is close enough that some published studies have used the human-sequence peptide in mice. That said, using a species-matched sequence is the cleaner approach when possible, since it removes any question about whether the small differences affected the result.

Rats are a slightly more complicated case. The rat MOTS-c sequence drifts a bit further from the human version than the mouse sequence does, which adds one more variable to account for. The field is still young, and papers do not always flag which sequence was used — so when comparing data across studies, it is worth tracking that down rather than assuming.

The related mitochondrial peptide SS-31 comes up in similar cross-species discussions — the post How SS-31 Works: Protecting Cells from the Inside covers some structural principles that apply broadly to mitochondria-targeted peptide research.

[PERSONAL EXPERIENCE] When researchers contact us about MOTS-c for rodent studies, the first thing we ask is whether they need the human sequence or a species-matched one. That one question has caught several mismatches before synthesis — much easier to fix at the ordering stage than after the experiment is already running.

Conserved residues as functional fingerprints

Looking beyond mice and rats, the MOTS-c sequence is recognizable across a much wider range of mammals — primates like macaques and chimpanzees have sequences nearly identical to the human version, while more distantly related mammals show more differences. The peptide does not seem to be a quirk of one particular lineage; it appears to be a real signal that has been around for a long time across the mammalian family tree.

For researchers interested in which parts of the peptide are doing the most work, this cross-species conservation map functions as a hypothesis guide. Swap out a conserved amino acid — one that is identical across species — and you would expect a large change in behavior. Swap out a variable one — a position where species already differ without obvious consequence — and the effect is likely smaller. This approach, called alanine scanning (systematically replacing one amino acid at a time with alanine, a neutral stand-in), is one way researchers map out which positions on a short peptide actually matter.

  • Primate sequences (macaque, chimpanzee) are nearly identical to the human MOTS-c sequence
  • Differences grow progressively larger in mammals more distantly related to humans
  • The broader gene context around MOTS-c in mitochondrial DNA is also conserved, even when individual amino acids differ
  • Public sequence records are available through NCBI’s mitochondrial genome database

Sourcing MOTS-c for cross-species research

When a study needs to compare MOTS-c activity across species or sequence variants, the peptide itself has to be well characterized from the start. Batch-to-batch differences in purity, or an undetected sequence error, can introduce problems that are nearly impossible to trace once the experiment is running. Alpha Peptides provides MOTS-c with HPLC purity verification and a Certificate of Analysis for every lot — the minimum documentation needed for any cross-species comparison that will hold up to scrutiny.

Because the human and mouse sequences differ at a small number of positions, specifying which variant you need at the time of ordering matters. Confirming sequence identity by mass spectrometry on receipt — and keeping that data with the study records — is standard practice for any work that will be compared against published literature.

Frequently asked questions about MOTS-c sequence conservation across species

Is the MOTS-c sequence identical in humans and mice?

No, but it is highly similar. Most of the 16 amino acids match, and the differences are mostly in the middle of the sequence (roughly positions 7 through 12). The first three and last three amino acids are the same in both species. Researchers should always check which version of the sequence was used in a study before comparing its results with others.

Why does sequence conservation matter for preclinical MOTS-c research?

When the peptide sequence is nearly the same in mice and humans, there is more reason to expect that findings in mice will be relevant to the human peptide. Where the sequences differ, the peptide may interact with its targets a little differently in each species, which can create gaps between rodent data and what you might see in a different context. Knowing which amino acids differ — and where they sit in the sequence — helps researchers flag those caveats when they interpret results.

Which residues are most conserved in the MOTS-c sequence across species?

The first three amino acids (Met-Arg-Trp, positions 1-3) and the last three (Lys-Leu-Arg, positions 14-16) are identical across human, mouse, and rat. These end sections are widely thought to be important for how the peptide folds and what it interacts with inside cells. The central GYIFY stretch (positions 7-11) shows more variation between species, though the changes tend to be chemically similar swaps rather than major shifts in character.

Where can researchers find publicly available MOTS-c sequence data for comparison?

The NCBI Nucleotide database has complete mitochondrial genome records for human (NC_012920), mouse (NC_005089), and rat (NC_001665). All three include the 12S rRNA gene region where MOTS-c is encoded. Running a BLAST alignment — a standard online tool that compares sequences side by side — across those records is a quick way to generate a position-by-position map of where the sequences agree and where they differ.


For research use only. Not for human consumption. All peptides available through Alpha Peptides are experimental compounds intended exclusively for laboratory and preclinical research. Explore the full catalog at alpha-peptides.com/shop/ and review Certificates of Analysis.